Package 31722-838-30

{"route": ["ORAL"], "spl_id": "366cb4c4-0386-17b7-e063-6394a90a5fd1", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0331722838306"], "unii": ["J220T4J9Q2", "2T8Q726O95"], "rxcui": ["602393"], "spl_set_id": ["e8988924-c18c-4e91-ab79-2d84e72bfa0d"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-838-30)  / 30 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "31722-838-30", "marketing_start_date": "20250416"}], "brand_name": "ABACAVIR and LAMIVUDINE", "product_id": "31722-838_366cb4c4-0386-17b7-e063-6394a90a5fd1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-838", "generic_name": "ABACAVIR and LAMIVUDINE", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ABACAVIR and LAMIVUDINE", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "600 mg/1"}, {"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA205412", "marketing_category": "ANDA", "marketing_start_date": "20250416", "listing_expiration_date": "20261231"}